Details for New Drug Application (NDA): 072023
✉ Email this page to a colleague
NDA 072023 describes PROMETA, which is a drug marketed by Muro and is included in two NDAs. Additional details are available on the PROMETA profile page.
The generic ingredient in PROMETA is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.
The generic ingredient in PROMETA is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.
Summary for 072023
| Tradename: | PROMETA |
| Applicant: | Muro |
| Ingredient: | metaproterenol sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072023
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 10MG/5ML | ||||
| Approval Date: | Sep 15, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
